These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15167294)

  • 21. Recent incarceration independently associated with syringe sharing by injection drug users.
    Wood E; Li K; Small W; Montaner JS; Schechter MT; Kerr T
    Public Health Rep; 2005; 120(2):150-6. PubMed ID: 15842116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of sex partners' HIV status on HIV seroconversion in a prospective cohort of injection drug users.
    Kerr T; Stoltz JA; Strathdee S; Li K; Hogg RS; Montaner JS; Wood E
    J Acquir Immune Defic Syndr; 2006 Jan; 41(1):119-23. PubMed ID: 16340484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Cedar project: prevalence and correlates of HIV infection among young Aboriginal people who use drugs in two Canadian cities.
    Spittal PM; Craib KJ; Teegee M; Baylis C; Christian WM; Moniruzzaman AK; Schechter MT;
    Int J Circumpolar Health; 2007 Jun; 66(3):226-40. PubMed ID: 17655063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
    Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV;
    AIDS; 2020 Jul; 34(9):1347-1358. PubMed ID: 32590433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?
    Vickerman P; Martin NK; Roy A; Beattie T; Jarlais DD; Strathdee S; Wiessing L; Hickman M;
    Drug Alcohol Depend; 2013 Sep; 132(1-2):172-81. PubMed ID: 23453261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody in British Columbia.
    Buxton JA; Rothon D; Durigon M; Lem M; Tu AW; Remple VP; Cook D; Krajden M
    Can J Public Health; 2009; 100(2):121-4. PubMed ID: 19839288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Needle exchange is not enough: lessons from the Vancouver injecting drug use study.
    Strathdee SA; Patrick DM; Currie SL; Cornelisse PG; Rekart ML; Montaner JS; Schechter MT; O'Shaughnessy MV
    AIDS; 1997 Jul; 11(8):F59-65. PubMed ID: 9223727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan.
    Yen YF; Yen MY; Su LW; Li LH; Chuang P; Jiang XR; Deng CY
    BMC Public Health; 2012 Dec; 12():1066. PubMed ID: 23227904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coinfection with HIV and hepatitis C virus in injection drug users and minority populations.
    Strader DB
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S7-13. PubMed ID: 16265618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
    Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
    Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada.
    Jacka B; Roy É; Høj S; Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Bruneau J
    J Viral Hepat; 2019 Dec; 26(12):1413-1422. PubMed ID: 31433888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China.
    Zhang C; Yang R; Xia X; Qin S; Dai J; Zhang Z; Peng Z; Wei T; Liu H; Pu D; Luo J; Takebe Y; Ben K
    J Acquir Immune Defic Syndr; 2002 Feb; 29(2):191-6. PubMed ID: 11832691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
    Solomon SS; Srikrishnan AK; Mehta SH; Vasudevan CK; Murugavel KG; Thamburaj E; Anand S; Kumar MS; Latkin C; Solomon S; Celentano DD
    J Acquir Immune Defic Syndr; 2008 Nov; 49(3):327-32. PubMed ID: 18845962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6.
    López-Zetina J; Ford W; Weber M; Barna S; Woerhle T; Kerndt P; Monterroso E
    Sex Transm Infect; 2000 Dec; 76(6):462-9. PubMed ID: 11221130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities.
    Spittal PM; Pearce ME; Chavoshi N; Christian WM; Moniruzzaman A; Teegee M; Schechter MT
    BMC Public Health; 2012 Aug; 12():632. PubMed ID: 22877418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention.
    Wood E; Spittal PM; Kerr T; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    Can J Public Health; 2003; 94(5):355-9. PubMed ID: 14577743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study.
    Ahamad K; Hayashi K; Nguyen P; Dobrer S; Kerr T; Schütz CG; Montaner JS; Wood E
    Lancet HIV; 2015 Oct; 2(10):e445-50. PubMed ID: 26423652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study).
    Evans JL; Hahn JA; Page-Shafer K; Lum PJ; Stein ES; Davidson PJ; Moss AR
    J Urban Health; 2003 Mar; 80(1):137-46. PubMed ID: 12612103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users.
    Gyarmathy VA; Neaigus A; Miller M; Friedman SR; Des Jarlais DC
    J Acquir Immune Defic Syndr; 2002 Aug; 30(4):448-56. PubMed ID: 12138352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.